Legal Representation
Attorney
Jun-Hwa Jeong
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 16, 2023 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | Loading... |
| Feb 16, 2023 | 8.OK | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED | Loading... |
| Feb 15, 2023 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | Loading... |
| Jan 6, 2023 | PRA8 | O | POST REGISTRATION ACTION MAILED - SEC. 8 | Loading... |
| Jan 6, 2023 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jul 12, 2022 | ES8R | I | TEAS SECTION 8 RECEIVED | Loading... |
| May 16, 2022 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| May 16, 2017 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 8, 2017 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 7, 2017 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Oct 13, 2016 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 13, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 13, 2016 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Sep 22, 2016 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Sep 7, 2016 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 15, 2016 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Aug 15, 2016 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Feb 23, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 29, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 29, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 9, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 13, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 10, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 9, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 9, 2015 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 14, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 14, 2015 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 14, 2015 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 7, 2015 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 9, 2015 | MPMK | E | NOTICE OF PSEUDO MARK E-MAILED | Loading... |
| Jan 8, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 1, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
biological enzyme not for medical purposes; cDNA synthesizing compositions for research purpose; cDNA synthesizing kits for research purposes comprised primarily of reagents, buffers, reverse transcriptase and oligo; nucleic acid fluorescence staining compositions for research purpose; nucleic acid fluorescence staining kits for research purposes comprised primarily of reagents, buffers, and dyes; DNA sequence analyzing compositions for research purpose; DNA sequence analyzing kits for research purposes comprised primarily of reagents, buffers and DNA polymerase; nucleic acid polymerase for research purpose; nucleic acid amplifying compositions for research purpose; nucleic acid amplifying kits for research purposes comprised primarily of regents, buffers, and nucleic acid polymerase; chemical reagent for research purpose; restriction enzyme for research purpose; polymerase chain reaction compositions for research purpose; reverse transcription compositions for research purpose
First Use Anywhere:
Aug 10, 2015
First Use in Commerce:
Sep 14, 2015
Class 005
biological enzyme for medical purposes; cDNA synthesizing compositions for medical purposes; cDNA synthesizing kits for medical purposes comprised primarily of regents, buffers, reverse transcriptase and oligo; nucleic acid fluorescence staining compositions for medical purposes; nucleic acid fluorescence staining kits for medical purposes comprised primarily of reagents, buffers, and dyes; DNA sequence analyzing compositions for medical purposes; DNA sequence analyzing kits for medical purpose comprised primarily of reagents, buffers and DNA polymerase; nucleic acid polymerase for medical purposes; nucleic acid amplifying compositions for medical purposes; nucleic acid amplifying kits for medical purposes comprised primarily of reagents, buffers, and nucleic acid polymerase; chemical reagent for medical purposes; restriction enzyme for medical purposes; polymerase chain reaction compositions for medical purposes; reverse transcription compositions for medical purposes
First Use Anywhere:
Aug 10, 2015
First Use in Commerce:
Sep 14, 2015
Additional Information
Pseudo Mark
DUAL-HOT START
Classification
International Classes
001
005